対馬 那由多 (ツシマ ナユタ)

北海道大学病院 脳・神経・感覚器科助教

研究者基本情報

■ 学位
  • 博士(医学), 北海道大学, 2024年03月
■ URL
researchmap URLホームページURL■ ID 各種
J-Global ID■ 研究キーワード・分野
研究分野
  • ライフサイエンス, 耳鼻咽喉科学

経歴

■ 経歴
経歴
  • 2019年04月 - 現在
    北海道大学大学院医学研究院 耳鼻咽喉科・頭頸部外科学教室 助教, 日本国

研究活動情報

■ 論文
  • Resting heart rate as a prognostic indicator for patients with head and neck squamous cell carcinoma.
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Hiroshi Idogawa; Masaki Kakumu; Hayato Imanari; Akihiro Homma
    International journal of clinical oncology, 31, 7, 1326, 1335, 2026年07月, [査読有り], [筆頭著者], [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Elevated resting heart rate (RHR) has been associated with poor prognosis in various cancers, but its significance in head and neck cancer (HNC) remains unclear. This study aimed to evaluate the prognostic impact of RHR and its association with the incidence of second primary cancer (SPC). METHODS: We retrospectively analyzed 213 patients with oropharyngeal, hypopharyngeal, or laryngeal squamous cell carcinoma who underwent chemoradiotherapy. Pretreatment RHR was measured from electrocardiograms, and survival outcomes were analyzed using Kaplan-Meier and Cox regression models. RESULTS: Patients with an RHR ≥ 83 bpm had significantly worse overall survival (P = 0.004) and disease-specific survival (P < 0.001). Elevated RHR was an independent prognostic factor and was associated with an increased incidence of SPC (P = 0.016), particularly esophageal cancer (P = 0.003). In exploratory analyses, this association with esophageal SPC remained after adjustment for alcohol consumption category and smoking status. CONCLUSIONS: RHR is a potential prognostic marker in HNC and, in exploratory analyses, was associated with an increased risk of SPCs, particularly esophageal cancer. These findings suggest that RHR may help stratify risk in patients with HNC, although further studies are needed to clarify its clinical implications.
  • 耳下腺癌におけるリンパ節転移の評価 予後的知見と治療戦略
    加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 本間 明宏
    日本癌治療学会学術集会抄録集, 63回, O79, 1, (一社)日本癌治療学会, 2025年10月
    英語
  • A Challenging Diagnosis of Laryngeal Neuroendocrine Tumor (NET): Final Classification as NET Grade 3 After Total Laryngectomy.
    Naoya Sanda; Nayuta Tsushima; Hayato Imanari; Akihiro Homma
    Cureus, 17, 8, e90729, 2025年08月, [国際誌]
    英語, 研究論文(学術雑誌), Laryngeal neuroendocrine neoplasms (NENs) are rare tumors that account for a small proportion of all laryngeal malignancies. They exhibit a wide range of differentiation and proliferative activity, and are often graded accordingly, using markers such as mitotic count and Ki-67 labeling index. We present the case of a 76-year-old man with progressive dysphagia and a supraglottic mass. Initial biopsy findings were inconclusive, raising suspicion of poorly differentiated carcinoma or metastatic disease. A re-biopsy of the larynx under general anesthesia and neck dissection revealed features consistent with neuroendocrine tumor (NET) Grade 2 (Ki-67 index 17%). Due to the limited efficacy of nonsurgical treatments and absence of somatostatin receptor expression, total laryngectomy was performed. Histopathological analysis of the resected specimen demonstrated increased mitotic activity and a Ki-67 index of 28%, leading to a revised diagnosis of NET Grade 3. This case highlights the diagnostic limitations of small biopsy specimens in the head and neck region and underscores the importance of stepwise evaluation, including surgical pathology, in establishing an accurate diagnosis and guiding curative treatment decisions in rare laryngeal NETs.
  • Running pattern of the internal maxillary artery assessed using arterial-phase CT images in 434 sides in Japanese individuals.
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Seijiro Hamada; Hiroshi Idogawa; Ryohei Katsumata; Akihiro Homma
    Auris, nasus, larynx, 52, 4, 398, 403, 2025年08月, [査読有り], [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVE: The internal maxillary artery (IMA) follows two primary running patterns: lateral, where it traverses the superficial layer of the lateral pterygoid muscle, and medial, where it passes through the deep layer. The frequency of these patterns varies among populations, with the medial type reported in 6-18 % of Asians and 37-46 % of Caucasians. Ligation of the IMA, commonly performed during total or partial maxillectomy to reduce bleeding, is more challenging in the medial type due to its deeper anatomical position. Therefore, preoperative identification of its pattern is crucial. This study analyzed the IMA running pattern in Japanese individuals using arterial-phase CT and the diagnostic accuracy of standard contrast-enhanced CT. METHODS: We retrospectively analyzed 434 sides from 217 Japanese individuals who underwent arterial-phase CT. The IMA was classified as lateral or medial based on its relationship with the lateral pterygoid muscle. We evaluated whether the running pattern was influenced by anatomical side, gender, or the side of tumor involvement using Fisher's exact test. In 213 patients, arterial-phase CT findings were compared with standard contrast-enhanced CT. RESULTS: The lateral and medial types were observed in 94 % (407 sides) and 6.2 % (27 sides), respectively. No significant differences were found between anatomical sides (p = 0.11), gender (p = 0.092), or tumor involvement (p = 0.57), though symmetry was significant (p = 0.003). Standard contrast-enhanced CT showed 97.4 % concordance with arterial-phase CT but misclassified 17 % of medial cases. CONCLUSION: The lateral type was predominant in Japanese individuals. Preoperative assessment of the IMA using arterial-phase CT is recommended when standard CT is inconclusive. Accurate identification can improve surgical precision and reduce complications.
  • 鼻副鼻腔悪性腫瘍放射線治療後の晩期障害:放射線治療の種類による違いについて
    安田 耕一; 高橋 周平; 井戸川 寛志; 鈴木 崇祥; 対馬 那由多; 木下 留美子; 加納 里志; 本間 明宏
    頭頸部癌, 51, 2, 178, 178, (一社)日本頭頸部癌学会, 2025年05月
    日本語
  • 当院における再発・転移頭頸部癌に対するS-1/セツキシマブ併用療法の治療成績
    田口 純; 清水 康; 井戸川 寛志; 鈴木 崇祥; 対馬 那由多; 加納 里志; 本間 明宏
    頭頸部癌, 51, 2, 180, 180, (一社)日本頭頸部癌学会, 2025年05月
    日本語
  • 胸腔鏡(VATS)アプローチを併用して頸部から摘出した縦隔甲状腺腫の3症例
    中村 輔; 加納 里志; 審 一範; 勝俣 量平; 浜田 誠二郎; 井戸川 寛志; 対馬 那由多; 本間 明宏
    日本気管食道科学会会報, 76, 2, s30, s30, (NPO)日本気管食道科学会, 2025年04月
    日本語
  • Improved local control and survival outcomes with RADPLAT in T4 oropharyngeal cancer: a retrospective study
    Satoshi Kano; Takayoshi Suzuki; Daisuke Yoshida; Nayuta Tsushima; Hiroshi Idogawa; Ryohei Katsumata; Koichi Yasuda; Naoya Kinota; Koji Yamasaki; Yasushi Shimizu; Jun Taguchi; Hidefumi Aoyama; Akihiro Homma
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025年03月27日
    英語, 研究論文(学術雑誌)
  • Improved local control and survival outcomes with RADPLAT in T4 oropharyngeal cancer: a retrospective study.
    Satoshi Kano; Takayoshi Suzuki; Daisuke Yoshida; Nayuta Tsushima; Hiroshi Idogawa; Ryohei Katsumata; Koichi Yasuda; Naoya Kinota; Koji Yamasaki; Yasushi Shimizu; Jun Taguchi; Hidefumi Aoyama; Akihiro Homma
    International journal of clinical oncology, 2025年03月27日, [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUNDS: Standard treatments for locally advanced oropharyngeal cancer (OPC) include surgery and chemoradiotherapy (CRT). While surgery offers good tumor control, it often results in significant postoperative functional impairments. Conversely, intravenous chemoradiotherapy (IV-CRT) is less effective in controlling primary tumors in T4 OPC cases and offers limited options for salvage surgery after recurrence. RADPLAT, a treatment involving intra-arterial cisplatin combined with radiotherapy, has demonstrated favorable results for other cancers and may offer an alternative treatment for OPC. METHODS: This retrospective study compared the efficacy and safety of RADPLAT and IV-CRT in the patients with T4 OPC treated at Hokkaido University Hospital between 2003 and 2022. The primary endpoint was local recurrence-free survival (LRFS), and the secondary endpoint was overall survival (OS). RESULTS: Fifty-six patients were included, with 29 in the RADPLAT group and 27 in the IV-CRT group. The RADPLAT group showed significantly better LRFS (2-year LRFS: 82.3%) and OS (5-year OS: 73.8%) compared to the IV-CRT group (2y-LRFS: 66.0%, 5y-OS: 45.7%). Multivariate analysis identified RADPLAT as an independent favorable prognostic factor for both LRFS and OS. There was no significant difference in the incidence of adverse events between the two groups, although grade 3 or higher mucositis was more common in the RADPLAT group. Swallowing function and tracheostomy rates were similar between the groups. CONCLUSION: RADPLAT provides superior local control and survival outcomes compared to IV-CRT for T4 OPC, with comparable safety and functional preservation. These findings suggest that RADPLAT may be a promising alternative to IV-CRT for cases with T4 OPC.
  • Dual-type deep learning-based image reconstruction for advanced denoising and super-resolution processing in head and neck T2-weighted imaging.
    Noriyuki Fujima; Yukie Shimizu; Yohei Ikebe; Hiroyuki Kameda; Taisuke Harada; Nayuta Tsushima; Satoshi Kano; Akihiro Homma; Jihun Kwon; Masami Yoneyama; Kohsuke Kudo
    Japanese journal of radiology, 2025年03月05日, [国内誌]
    英語, 研究論文(学術雑誌), PURPOSE: To assess the utility of dual-type deep learning (DL)-based image reconstruction with DL-based image denoising and super-resolution processing by comparing images reconstructed with the conventional method in head and neck fat-suppressed (Fs) T2-weighted imaging (T2WI). MATERIALS AND METHODS: We retrospectively analyzed the cases of 43 patients who underwent head/neck Fs-T2WI for the assessment of their head and neck lesions. All patients underwent two sets of Fs-T2WI scans with conventional- and DL-based reconstruction. The Fs-T2WI with DL-based reconstruction was acquired based on a 30% reduction of its spatial resolution in both the x- and y-axes with a shortened scan time. Qualitative and quantitative assessments were performed with both the conventional method- and DL-based reconstructions. For the qualitative assessment, we visually evaluated the overall image quality, visibility of anatomical structures, degree of artifact(s), lesion conspicuity, and lesion edge sharpness based on five-point grading. In the quantitative assessment, we measured the signal-to-noise ratio (SNR) of the lesion and the contrast-to-noise ratio (CNR) between the lesion and the adjacent or nearest muscle. RESULTS: In the qualitative analysis, significant differences were observed between the Fs-T2WI with the conventional- and DL-based reconstruction in all of the evaluation items except the degree of the artifact(s) (p < 0.001). In the quantitative analysis, significant differences were observed in the SNR between the Fs-T2WI with conventional- (21.4 ± 14.7) and DL-based reconstructions (26.2 ± 13.5) (p < 0.001). In the CNR assessment, the CNR between the lesion and adjacent or nearest muscle in the DL-based Fs-T2WI (16.8 ± 11.6) was significantly higher than that in the conventional Fs-T2WI (14.2 ± 12.9) (p < 0.001). CONCLUSION: Dual-type DL-based image reconstruction by an effective denoising and super-resolution process successfully provided high image quality in head and neck Fs-T2WI with a shortened scan time compared to the conventional imaging method.
  • Effective management of continuous salivary flow through a pharyngocutaneous fistula using a negative pressure wound therapy device
    Taku Maeda; Nayuta Tsushima; Kosuke Ishikawa; Yuhei Yamamoto
    JPRAS Open, Elsevier BV, 2024年11月
    研究論文(学術雑誌)
  • 北日本13施設における唾液腺導管癌症例の検討
    加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 浜田 誠二郎; 大越 明; 日下 尚裕; 松下 大佑; 村山 公介; 佐藤 遼介; 宮倉 裕也; 久保田 叡; 登米 慧; 田川 愛; 神戸 史乃; 富澤 宏基; 白鳥 秋菜; 本間 明宏
    頭頸部癌, 50, 3, 246, 253, (一社)日本頭頸部癌学会, 2024年10月
    日本語
  • 頭頸部悪性腫瘍全国登録を用いた日本の中咽頭扁平上皮癌の現況と治療成績の解析
    加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 勝俣 量平; 川北 大介; 吉本 世一; 丹生 健一; 本間 明宏
    日本癌治療学会学術集会抄録集, 62回, O67, 4, (一社)日本癌治療学会, 2024年10月
    英語
  • [ANL Secondary Publication] 平均赤血球容積高値は頭頸部癌に食道癌を併発するリスク因子である
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 127, 9, 1027, 1029, (一社)日本耳鼻咽喉科頭頸部外科学会, 2024年09月
    日本語
  • 鼻副鼻腔粘膜悪性黒色腫におけるTRIM27の検討
    木村 将吾; 中丸 裕爾; 鈴木 正宣; 中薗 彬; 本間 あや; 渡邉 良亮; 加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 本間 明宏; 渡部 昌; 近藤 豪; 畠山 鎮次
    日本鼻科学会会誌, 63, 3, 336, 336, (一社)日本鼻科学会, 2024年09月
    日本語
  • [ANL Secondary Publication] 平均赤血球容積高値は頭頸部癌に食道癌を併発するリスク因子である
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 127, 9, 1027, 1029, (一社)日本耳鼻咽喉科頭頸部外科学会, 2024年09月
    日本語
  • 鼻副鼻腔粘膜悪性黒色腫におけるTRIM27の検討
    木村 将吾; 中丸 裕爾; 鈴木 正宣; 中薗 彬; 本間 あや; 渡邉 良亮; 加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 本間 明宏; 渡部 昌; 近藤 豪; 畠山 鎮次
    日本鼻科学会会誌, 63, 3, 336, 336, (一社)日本鼻科学会, 2024年09月
    日本語
  • 心拍数高値は頭頸部癌化学放射線療法における予後不良因子である
    対馬 那由多; 加納 里志; 鈴木 崇祥; 井戸川 寛志; 本間 明宏
    頭頸部癌, 50, 2, 155, 155, (一社)日本頭頸部癌学会, 2024年05月
    日本語
  • 早期声門癌に対する強度変調放射線治療の初期経験
    服部 敬寛; 安田 耕一; 湊川 英樹; 打浪 雄介; 木下 留美子; 浜田 誠二郎; 井戸川 寛志; 鈴木 崇祥; 対馬 那由多; 加納 里志; 本間 明宏
    頭頸部癌, 50, 2, 206, 206, (一社)日本頭頸部癌学会, 2024年05月
    日本語
  • 遠隔転移のない頭頸部粘膜悪性黒色腫を対象とした根治治療に関する観察研究(RESUME試験)
    茂木 厚; 野村 基雄; 清田 尚臣; 清水 康; 秋元 哲夫; 向川 卓志; 藤井 隆; 対馬 那由多; 志賀 清人; 小山 泰司; 川北 大介; 大越 明; 中平 光彦; 花井 信広; 室野 重之; 上田 勉; 三谷 浩樹; 本間 明宏
    頭頸部癌, 50, 2, 192, 192, (一社)日本頭頸部癌学会, 2024年05月
    日本語
  • 頭頸部アルミノックス治療における複合現実を用いた治療計画の3次元可視化の試み
    鈴木 崇祥; 足利 雄一; 若林 侑輝; 鈴木 正宣; 浜田 誠二郎; 井戸川 寛志; 対馬 那由多; 加納 里志; 本間 明宏
    頭頸部癌, 50, 2, 189, 189, (一社)日本頭頸部癌学会, 2024年05月
    日本語
  • SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy.
    Takayoshi Suzuki; Satoshi Kano; Masanobu Suzuki; Seijiro Hamada; Hiroshi Idogawa; Nayuta Tsushima; Yuichi Ashikaga; Yuki Wakabayashi; Takeshi Soyama; Yasuhiro Hida; Akihiro Homma
    International journal of clinical oncology, 2024年04月23日, [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Photoimmunotherapy is a treatment modality that induces targeted cell death by binding a molecular-targeted drug activated by infrared light to the tumor cells and subsequently illuminating the lesion with infrared light. For deep lesions, a needle catheter is used to puncture the tumor, and an illumination fiber (cylindrical diffuser) is inserted into the catheter lumen for internal illumination. However, it can be challenging to place the cylindrical diffusers in an appropriate position as the deep lesions cannot be often confirmed accurately during surgery. MATERIALS AND METHODS: We have developed "SlicerPIT", a planning simulation software for photoimmunotherapy. SlicerPIT allows users to place the cylindrical diffuser with its illumination range on preoperative images in 2D and 3D and export the planning data to external image-guided surgical navigation systems. We performed seven cycles of photoimmunotherapy with SlicerPIT in three patients with recurrent head and neck cancer. RESULTS: Preoperative planning for photoimmunotherapy was conducted using SlicerPIT, which could be imported into the navigation system. During the operation, we punctured the needle catheters along with the treatment plan on the navigation screen. Subsequently, intraoperative CT imaging was performed and overlaid with the preoperative treatment plan to confirm the alignment of the cylindrical diffusers as planned, followed by infrared light illumination. Postoperative imaging showed necrosis and shrinkage of the entire tumor in all cycles. CONCLUSION: SlicerPIT allows for detailed preoperative treatment planning and accurate puncture. It may be a valuable tool to improve the accuracy of photoimmunotherapy for deep lesions and improve patient outcomes.
  • 鼻副鼻腔粘膜悪性黒色腫の遺伝子変異を次世代シークエンサーにより解析する
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 井戸川 寛志; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 127, 4, 540, 540, (一社)日本耳鼻咽喉科頭頸部外科学会, 2024年04月
    日本語
  • 治療計画ARナビゲーション・ニードルベンダーを用いた頭頸部アルミノックス治療の1例
    鈴木 崇祥; 足利 雄一; 若林 侑輝; 鈴木 正宣; 浜田 誠二郎; 井戸川 寛志; 対馬 那由多; 加納 里志; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 127, 4, 599, 599, (一社)日本耳鼻咽喉科頭頸部外科学会, 2024年04月
    日本語
  • Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
    Yusuke Uchinami; Koichi Yasuda; Hideki Minatogawa; Yasuhiro Dekura; Noboru Nishikawa; Rumiko Kinoshita; Kentaro Nishioka; Norio Katoh; Takashi Mori; Manami Otsuka; Naoki Miyamoto; Ryusuke Suzuki; Keiji Kobashi; Yasushi Shimizu; Jun Taguchi; Nayuta Tsushima; Satoshi Kano; Akihiro Homma; Hidefumi Aoyama
    Radiation oncology journal, 42, 1, 74, 82, 2024年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), PURPOSE: To investigate the clinical significance of adaptive radiotherapy (ART) in locally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS: Eligible patients were treated with concurrent chemoradiotherapy using IMRT. Planning computed tomography in ART was performed during radiotherapy, and replanning was performed. Since ART was started in May 2011 (ART group), patients who were treated without ART up to April 2011 (non-ART group) were used as the historical control. The Kaplan-Meier method was used to calculate overall survival (OS), locoregional recurrence-free survival (LRFS), progression-free survival (PFS), and distant metastasis-free survival (DMFS). LRFS for the primary tumor (LRFS_P) and regional lymph node (LRFS_LN) were also studied for more detailed analysis. Statistical significance was evaluated using the log-rank test for survival. RESULTS: The ART group tended to have higher radiation doses. The median follow-up period was 127 months (range, 10 to 211 months) in the non-ART group and 61.5 months (range, 5 to 129 months) in the ART group. Compared to the non-ART group, the ART group showed significantly higher 5-year PFS (53.8% vs. 81.3%, p = 0.015) and LRFS (61.2% vs. 85.3%, p = 0.024), but not OS (80.7% vs. 80.8%, p = 0.941) and DMFS (84.6% vs. 92.7%, p = 0.255). Five-year LRFS_P was higher in the ART group (61.3% vs. 90.6%, p = 0.005), but LRFS_LN did not show a significant difference (91.9% vs. 96.2%, p = 0.541). CONCLUSION: Although there were differences in the patient backgrounds between the two groups, this study suggests the potential effectiveness of ART in improving locoregional control, especially in the primary tumor.
  • Improved image quality in contrast-enhanced 3D-T1 weighted sequence by compressed sensing-based deep-learning reconstruction for the evaluation of head and neck.
    Noriyuki Fujima; Junichi Nakagawa; Yohei Ikebe; Hiroyuki Kameda; Taisuke Harada; Yukie Shimizu; Nayuta Tsushima; Satoshi Kano; Akihiro Homma; Jihun Kwon; Masami Yoneyama; Kohsuke Kudo
    Magnetic resonance imaging, 108, 111, 115, 2024年02月09日, [国際誌]
    英語, 研究論文(学術雑誌), PURPOSE: To assess the utility of deep learning (DL)-based image reconstruction with the combination of compressed sensing (CS) denoising cycle by comparing images reconstructed by conventional CS-based method without DL in fat-suppressed (Fs)-contrast enhanced (CE) three-dimensional (3D) T1-weighted images (T1WIs) of the head and neck. MATERIALS AND METHODS: We retrospectively analyzed the cases of 39 patients who had undergone head and neck Fs-CE 3D T1WI applying reconstructions based on conventional CS and CS augmented by DL, respectively. In the qualitative assessment, we evaluated overall image quality, visualization of anatomical structures, degree of artifacts, lesion conspicuity, and lesion edge sharpness based on a five-point system. In the quantitative assessment, we calculated the signal-to-noise ratios (SNRs) of the lesion and the posterior neck muscle and the contrast-to-noise ratio (CNR) between the lesion and the adjacent muscle. RESULTS: For all items of the qualitative analysis, significantly higher scores were awarded to images with DL-based reconstruction (p < 0.001). In the quantitative analysis, DL-based reconstruction resulted in significantly higher values for both the SNR of lesions (p < 0.001) and posterior neck muscles (p < 0.001). Significantly higher CNRs were also observed in images with DL-based reconstruction (p < 0.001). CONCLUSION: DL-based image reconstruction integrating into the CS-based denoising cycle offered superior image quality compared to the conventional CS method. This technique will be useful for the assessment of patients with head and neck disease.
  • Correction: Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma.
    Yusuke Uchinami; Koichi Yasuda; Satoshi Kano; Manami Otsuka; Seijiro Hamada; Takayoshi Suzuki; Nayuta Tsushima; Shuhei Takahashi; Yoshihiro Fujita; Tomohiko Miyazaki; Hajime Higaki; Jun Taguchi; Yasushi Shimizu; Tomohiro Sakashita; Akihiro Homma; Hidefumi Aoyama
    Discover. Oncology, 15, 1, 18, 18, 2024年01月25日, [国際誌]
    英語
  • Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations
    Nayuta Tsushima; Satoshi Kano; Kanako C. Hatanaka; Takayoshi Suzuki; Seijiro Hamada; Hiroshi Idogawa; Yuji Nakamaru; Masanobu Suzuki; Yutaka Hatanaka; Akihiro Homma
    Auris Nasus Larynx, Elsevier BV, 2024年01月13日, [査読有り], [筆頭著者]
    英語, 研究論文(学術雑誌), 40312446
  • Long-term results of nasolacrimal duct and inferior turbinate swing technique for inverted papilloma of the maxillary sinus.
    Yuji Nakamaru; Masanobu Suzuki; Ken Shizuki; Aya Honma; Akira Nakazono; Shogo Kimura; Ryosuke Watanabe; Satoshi Kano; Nayuta Tsushima; Takayoshi Suzuki; Akihiro Homma
    SAGE open medicine, 12, 20503121241271877, 20503121241271877, 2024年, [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: We developed a technique to preserve the entire nasolacrimal duct and inferior turbinate, by swinging the nasolacrimal duct upward and the inferior turbinate backward; that is, a nasolacrimal duct and inferior turbinate swing technique for sinonasal inverted papilloma of the maxillary sinus. In this study, we evaluated the long-term results of this technique. METHODS: A retrospective analysis was performed on the data for 53 consecutive pathologically confirmed inverted papilloma patients who were treated using nasolacrimal duct and inferior turbinate swing technique. The frequency of recurrence, the degree of nasolacrimal duct and inferior turbinate preservation, and the frequency of adverse events were assessed. RESULTS: The median follow-up period was 51 months (mean 62.5 months; range 10-187 months). No cases of recurrence within the maxillary sinus were observed among the cases treated using this technique, whereas three (5.7%) of the 53 cases experienced recurrence in areas other than the maxillary sinus. We could preserve the nasolacrimal duct in all cases. On the other hand, the inferior turbinate was resected during surgery in one case. No epiphora, dacryocystiits, numbness of the cheek, or collapse of the ala of the nose was observed. CONCLUSION: This nasolacrimal duct and inferior turbinate swing technique method is a safe and effective method for the excision of primary or recurrent inverted papilloma and demonstrates low rates of recurrence and complications.
  • Analysis of salivary duct carcinoma at 13 facilities in northern Japan
    Satoshi Kano; Nayuta Tsushima; Takayoshi Suzuki; Hiroshi Idogawa; Seijiro Hamada; Akira Ohkoshi; Takahiro Kusaka; Daisuke Matsushita; Kosuke Murayama; Ryosuke Sato; Yuya Miyakura; Satoshi Kubota; Satoshi Toyoma; Ai Tagawa; Shino Godo; Hiroki Tomizawa; Akina Shirotori; Akihiro Homma
    Toukeibu Gan, 50, 3, 246, 253, Japan Society for Head and Neck Cancer, 2024年
    研究論文(学術雑誌)
  • Clinical outcomes for olfactory neuroblastoma.
    Akira Nakazono; Hiroaki Motegi; Masanobu Suzuki; Yuji Nakamaru; Shigeru Yamaguchi; Yukitomo Ishi; Satoshi Kano; Nayuta Tsushima; Aya Honma; Takayoshi Suzuki; Shogo Kimura; Seijiro Hamada; Jun Taguchi; Yasushi Shimizu; Takashi Mori; Koichi Yasuda; Hidefumi Aoyama; Ichiro Kinoshita; Miki Fujimura; Akihiro Homma
    Frontiers in oncology, 14, 1329572, 1329572, 2024年, [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Olfactory neuroblastoma (ONB) is a rare malignant tumor arising from the olfactory neuroepithelium. The standard of care for ONB is surgical resection; however, detailed treatment protocols vary by institution. Our treatment protocol consists of endoscopic skull base surgery (ESBS) for endoscopically resectable cases and induction chemotherapy followed by craniotomy combined with ESBS for locally advanced cases, with postoperative radiotherapy performed for all cases. Chemoradiotherapy (CRT) is performed in unresectable cases. In this study, we evaluate our treatment protocol and outcomes for ONB. METHODS: A retrospective review of patients with ONB was conducted. Outcomes included survival outcomes and perioperative data. RESULTS: Fifteen patients (53.6%) underwent ESBS, 12 (42.9%) underwent craniotomy combined with ESBS, and 1 (3.6%) received CRT. The 5- and 10-year overall survival rates for all patients were 92.9% and 82.5%, respectively, with a median follow-up period of 81 months. The 5- and 10-year disease-free survival rates were 77.3% and 70.3%, respectively, and the 5- and 10-year local control rates were 88.2% and 80.2%, respectively. Patients undergoing ESBS demonstrated a significantly shorter operating time, period from operation to ambulation, hospitalization period, and less blood loss than those undergoing craniotomy combined with ESBS. CONCLUSION: Our treatment protocol was found to afford favorable outcomes. Patients who underwent endoscopic resection showed lower complication rates and better perioperative data than those who underwent craniotomy combined with ESBS. With appropriate case selection, ESBS is considered a useful approach for ONB.
  • Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma.
    Yusuke Uchinami; Koichi Yasuda; Satoshi Kano; Manami Otsuka; Seijiro Hamada; Takayoshi Suzuki; Nayuta Tsushima; Shuhei Takahashi; Yoshihiro Fujita; Tomohiko Miyazaki; Hajime Higaki; Jun Taguchi; Yasushi Shimizu; Tomohiro Sakashita; Akihiro Homma; Hidefumi Aoyama
    Discover. Oncology, 14, 1, 226, 226, 2023年12月08日, [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Tri-weekly cisplatin and radiotherapy (CDDP + RT) is a standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) but is sometimes challenging to complete in older patients. Weekly CDDP + RT has shown mild toxicity compared to tri-weekly CDDP + RT for LA-HNSCC and is a promising option for older adults. We aimed to report the treatment outcomes and prognostic factors in patients with LA-HNSCC treated with weekly CDDP + RT. METHODS: We analyzed patients aged ≥ 70 years who started weekly CDDP + RT for LA-HNSCC between July 2006 and October 2022. LA-HNSCC includes cancer in the oropharynx, hypopharynx, or larynx with a clinical stage of 3 or 4 without distant metastases based on the Union for International Cancer Control staging system 8th edition. The radiation dose of 70 Gy was delivered in 35 fractions by 3-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy. The primary endpoint was the 3-year overall survival (OS), and the secondary endpoints were the 3-year progression-free survival (PFS) and 3-year cause-specific survival (CSS). The Kaplan-Meier method was used to calculate survival rates, and the log-rank test was used to evaluate statistical significance. A Cox proportional hazards model was used for the multivariate analysis of prognostic factors. RESULTS: The median age of the 49 patients was 72 (range: 70-78) years. The median CDDP dose was 200 (40-280) mg/ m2, and 47 patients completed scheduled radiotherapy. Forty-eight patients (98.0%) had a performance status of ≥ 1 at the initial visit. The 3-year OS, PFS, and CSS were 80.9% (95% confidence interval [CI]: 64.8-90.7), 68.3% (95% CI 51.8-81.2), and 85.0% (95% CI 68.7-93.4), respectively. In the multivariate analysis, the cumulative CDDP dose (< 200 or ≥ 200 mg/m2) was a significant factor for OS (hazard ratio: 0.29 [95% CI 0.08-0.97], p = 0.044). There was one case of early mortality. Grade 3 or higher late adverse events were observed in four patients (8.2%). CONCLUSIONS: Weekly CDDP + RT in older patients led to good survival outcomes with an acceptable rate of adverse events. CDDP should be administered at a dose of at least 200 mg/m2 in older patients. Trial registration Retrospectively registered.
  • Improvement of image quality in diffusion-weighted imaging with model-based deep learning reconstruction for evaluations of the head and neck.
    Noriyuki Fujima; Junichi Nakagawa; Hiroyuki Kameda; Yohei Ikebe; Taisuke Harada; Yukie Shimizu; Nayuta Tsushima; Satoshi Kano; Akihiro Homma; Jihun Kwon; Masami Yoneyama; Kohsuke Kudo
    Magma (New York, N.Y.), 2023年11月21日, [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVES: To investigate the utility of deep learning (DL)-based image reconstruction using a model-based approach in head and neck diffusion-weighted imaging (DWI). MATERIALS AND METHODS: We retrospectively analyzed the cases of 41 patients who underwent head/neck DWI. The DWI in 25 patients demonstrated an untreated lesion. We performed qualitative and quantitative assessments in the DWI analyses with both deep learning (DL)- and conventional parallel imaging (PI)-based reconstructions. For the qualitative assessment, we visually evaluated the overall image quality, soft tissue conspicuity, degree of artifact(s), and lesion conspicuity based on a five-point system. In the quantitative assessment, we measured the signal-to-noise ratio (SNR) of the bilateral parotid glands, submandibular gland, the posterior muscle, and the lesion. We then calculated the contrast-to-noise ratio (CNR) between the lesion and the adjacent muscle. RESULTS: Significant differences were observed in the qualitative analysis between the DWI with PI-based and DL-based reconstructions for all of the evaluation items (p < 0.001). In the quantitative analysis, significant differences in the SNR and CNR between the DWI with PI-based and DL-based reconstructions were observed for all of the evaluation items (p = 0.002 ~ p < 0.001). DISCUSSION: DL-based image reconstruction with the model-based technique effectively provided sufficient image quality in head/neck DWI.
  • Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
    Yasuhiro Dekura; Koichi Yasuda; Hideki Minatogawa; Yusuke Uchinami; Nayuta Tsushima; Takayoshi Suzuki; Satoshi Kano; Takashi Mori; Kentaro Nishioka; Keiji Kobashi; Norio Katoh; Akihiro Homma; Hidefumi Aoyama
    Journal of radiation research, 2023年11月10日, [国際誌]
    英語, 研究論文(学術雑誌), The objective of this study was to determine the outcomes of radical radiotherapy for early glottic squamous cell carcinoma (EGSCC) with the policy of increasing the fraction size during radiotherapy when the overall treatment time (OTT) was expected to be prolonged. Patients diagnosed with clinical T1-2N0M0 EGSCC, who were treated with radical radiotherapy between 2008 and 2019 at Hokkaido University Hospital, were included. Patients received 66 Gy in 33 fractions for T1 disease and 70 Gy in 35 fractions for T2 disease as our standard regimen (usual group [UG]). If the OTT was expected to extend for >1 week, the dose fraction size was increased from 2.0 to 2.5 Gy from the beginning or during radiotherapy (adjusted group [AG]). At this time, we performed a statistical analysis between UG and AG. In total, 116 patients were identified, and the treatment schedules of 29 patients were adjusted. The median follow-up was 60.9 months. In the T1 group, the cumulative 5-year local failure rate was 12.0% in the AG and 15.4% in the UG, and in the T2 group, the rate was 40.7% in the AG and 25.3% in the UG. There were no significant differences between the AG and UG. Similarly, no significant differences were observed for overall survival and progression-free survival rates. Our single-institutional retrospective analysis of EGSCC patients suggested that a method of adjusting the radiotherapy schedule to increase fraction size from the beginning or during the course may be effective in maintaining treatment outcomes.
  • 高悪性度唾液腺癌に対する術前診断モデルの開発
    加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 浜田 誠二郎; 本間 明宏
    日本癌治療学会学術集会抄録集, 61回, O30, 1, (一社)日本癌治療学会, 2023年10月
    英語
  • 涙道原発扁平上皮癌の3例
    滝沢 亮介; 対馬 那由多; 鈴木 崇祥; 加納 里志; 本間 明宏
    耳鼻咽喉科臨床, 116, 8, 765, 773, 耳鼻咽喉科臨床学会, 2023年08月
    日本語
  • Utility of Color Doppler Ultrasonography in Monitoring of a Free Jejunal Flap
    Taku Maeda; Kosuke Ishikawa; Yoichiro Oda; Satoshi Kano; Nayuta Tsushima; Tomohiro Sakashita; Akihiro Homma; Yuhei Yamamoto; Emi Funayama
    The Laryngoscope, Wiley, 2023年06月29日
    研究論文(学術雑誌)
  • Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy.
    Nayuta Tsushima; Satoshi Kano; Koichi Yasuda; Takayoshi Suzuki; Seijiro Hamada; Yuji Nakamaru; Masanobu Suzuki; Yusuke Uchinami; Hidefumi Aoyama; Akihiro Homma
    International journal of clinical oncology, 28, 9, 1218, 1226, 2023年06月17日, [査読有り], [筆頭著者], [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: The standard of care for sinonasal mucosal melanoma is surgery and postoperative radiotherapy (PORT). Our treatment strategy comprises endoscopic resection and PORT. We performed combined endoscopic and open resection or applied an external approach alone when sufficient resection was difficult to achieve endoscopically. The objective of this study was to evaluate the validity of our treatment strategy. METHODS: We assessed 30 patients with sinonasal mucosal melanoma who underwent definitive therapy between January 2002 and April 2021, and conducted a retrospective analysis. The median follow-up period was 2.2 years. The primary endpoint was overall survival. The Kaplan-Meier method was used for the calculation of survival rates, the cumulative incidence of distant metastasis, and local recurrence. RESULTS: Twenty-eight patients underwent surgery. The other two patients were treated by definitive proton beam therapy. Twenty-one of 28 (75%) patients underwent resection by endoscopic approach alone. Postoperative radiotherapy was performed for all 28 patients who underwent surgery. Twenty-one patients (70%) experienced recurrence during the observation period. Overall, distant metastasis was observed in 19 patients. Twelve patients died during the observation period, with 10 of the 12 patients (83%) dying of distant metastasis. The overall survival rate at 2 and 5 years was 70% and 46%, respectively. The cumulative incidence rate of distant metastasis at 2 years was 63%, while the 2-year cumulative incidence rate of local recurrence was 6.7%. CONCLUSION: The local disease was controlled by our treatment strategy. To improve treatment outcomes, control of the distant metastasis is needed.
  • The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
    Satoshi Kano; Takayoshi Suzuki; Daisuke Yoshida; Nayuta Tsushima; Seijiro Hamada; Koichi Yasuda; Yusuke Uchinami; Hidefumi Aoyama; Akihiro Homma
    International journal of clinical oncology, 28, 9, 1121, 1128, 2023年06月08日, [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is a very promising treatment modality for locally advanced head and neck squamous cell carcinoma. However, there are some concerns regarding its potential for the control of neck lymph node metastasis. The objective of this study was to investigate whether RADPLAT provided inferior regional control compared to intravenous chemoradiotherapy (IV-CRT). METHODS: A total of 172 patients with neck lymph node metastases, 66 of whom underwent RADPLAT and 106 IV-CRT, were enrolled in this study. We retrospectively compared regional control rates between RADPLAT and IV-CRT. Furthermore, to adjust for differences in factors related to patient background between the groups, we conducted inverse probability weighting (IPW) analysis using the propensity score. RESULTS: A comparison between the two groups revealed that the regional control rates were almost equal under unadjusted conditions; however, after adjustment by IPW analysis, the RADPLAT group had a relatively better regional control rate than did the IV-CRT group (1 year regional control rate: 86.6% vs. 79.4%). In addition, the analysis of relative risk factors for regional control in the RADPLAT group showed that the absence of intra-arterial cisplatin infusion into metastatic lymph nodes was the only independent risk factor (Hazard ratio: 4.23, p = 0.04). CONCLUSION: This study showed that the regional control rate in patients treated with RADPLAT was noninferior to that for IV-CRT. Locally advanced head and neck cancers is a good indication for RADPLAT, even if the patients have neck lymph node metastases.
  • 摘出に難渋した口腔底魚骨異物の1例
    関 宏樹; 鈴木 崇祥; 加納 里志; 対馬 那由多; 横川 泰三; 本間 明宏
    耳鼻咽喉科臨床 補冊, 補冊161, 136, 136, 耳鼻咽喉科臨床学会, 2023年06月
    日本語
  • 次世代シークエンサーによる鼻副鼻腔粘膜悪性黒色腫の遺伝子発現解析
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 安田 耕一; 清水 康; 田口 純; 本間 明宏
    頭頸部癌, 49, 2, 133, 133, (一社)日本頭頸部癌学会, 2023年05月
    日本語
  • 頭頸部癌に対する化学放射線療法の効果予測マーカーとしてのSLFN11の有用性
    浜田 誠二郎; 加納 里志; 鈴木 崇祥; 対馬 那由多; 本間 明宏
    頭頸部癌, 49, 2, 187, 187, (一社)日本頭頸部癌学会, 2023年05月
    日本語
  • SlicerPIT 頭頸部アルミノックス治療の治療計画ソフトウェアの開発
    鈴木 崇祥; 足利 雄一; 若林 侑輝; 勝俣 量平; 浜田 誠二郎; 井戸川 寛志; 対馬 那由多; 加納 里志; 本間 明宏
    頭頸部癌, 49, 2, 127, 127, (一社)日本頭頸部癌学会, 2023年05月
    日本語
  • 高齢者の局所進行頭頸部扁平上皮癌患者におけるweeklyシスプラチン併用放射線治療の治療成績
    打浪 雄介; 安田 耕一; 加納 里志; 対馬 那由多; 鈴木 崇祥; 浜田 誠二郎; 田口 純; 清水 康; 坂下 智博; 本間 明宏
    頭頸部癌, 49, 2, 134, 134, (一社)日本頭頸部癌学会, 2023年05月
    日本語
  • 当院で治療した頭頸部原発横紋筋肉腫症例の検討
    勝俣 量平; 加納 里志; 対馬 那由多; 鈴木 崇祥; 浜田 誠二郎; 清水 康; 田口 純; 安田 耕一; 打浪 雄介; 本間 明宏
    頭頸部癌, 49, 2, 161, 161, (一社)日本頭頸部癌学会, 2023年05月
    日本語
  • 唾液腺癌の局所頸部制御における術後照射の有用性の検討
    加納 里志; 対馬 那由多; 鈴木 崇祥; 浜田 誠二郎; 安田 耕一; 打浪 雄介; 本間 明宏
    頭頸部癌, 49, 2, 192, 192, (一社)日本頭頸部癌学会, 2023年05月
    日本語
  • TRIM27の鼻副鼻腔粘膜悪性黒色腫におけるバイオマーカーとしての検討
    木村 将吾; 中丸 裕爾; 鈴木 正宣; 本間 あや; 中薗 彬; 加納 里志; 対馬 那由多; 鈴木 崇祥; 浜田 誠二郎; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 126, 4, 562, 562, (一社)日本耳鼻咽喉科頭頸部外科学会, 2023年04月
    日本語
  • 頭頸部癌細胞株におけるSLFN11遺伝子発現と薬剤感受性の検討
    浜田 誠二郎; 加納 里志; 鈴木 崇祥; 対馬 那由多; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 126, 4, 600, 600, (一社)日本耳鼻咽喉科頭頸部外科学会, 2023年04月
    日本語
  • TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma.
    S Kimura; M Suzuki; Y Nakamaru; S Kano; M Watanabe; A Honma; A Nakazono; N Tsushima; S Hatakeyama; A Homma
    Rhinology, 2023年03月09日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Tripartite motif-containing 27 (TRIM27) has been implicated in the progression of various cancers. However, the role of TRIM27 in sinonasal mucosal melanoma (SNMM) remains poorly understood. MATERIALS & METHODS: We retrospectively examined 28 patients with SNMM treated with between 2003 and 2021. We undertook immunohistochemical analysis of TRIM27, Ki-67, and p-Akt1 expression in SNMM tissues. We also investigated the relationship between TRIM27 expression and clinical characteristics, prognosis, Ki-67 as a tumor growth potential marker, and p-Akt1 as one of the prognostic factors in mucosal melanoma. RESULTS: TRIM27 expression was significantly higher in T4 disease than in T3 disease and was higher in stage IV than in stage III. Patients with high-TRIM27 SNMM had a significantly poorer prognosis in terms of overall survival (OS) and disease-free survival.There was also a significantly higher rate of distant metastasis. Univariate analysis for OS revealed that TRIM27 and T classification were significant poor prognostic factors. In addition, the Ki-67 positive score and the p-Akt1 total staining score were significantly higher in the high-TRIM27 group than in the low-TRIM27 group. CONCLUSIONS: High TRIM27 expression in SNMM was associated with advanced T classification, poor prognosis and distant metastasis. We suggest that TRIM27 has potential as a novel biomarker for prognosis in SNMM.
  • Detailed analysis of failure patterns using deformable image registration in hypopharyngeal cancer patients treated with sequential boost intensity-modulated radiotherapy.
    Manami Otsuka; Koichi Yasuda; Yusuke Uchinami; Nayuta Tsushima; Takayoshi Suzuki; Satoshi Kano; Ryusuke Suzuki; Naoki Miyamoto; Hideki Minatogawa; Yasuhiro Dekura; Takashi Mori; Kentaro Nishioka; Jun Taguchi; Yasushi Shimizu; Norio Katoh; Akihiro Homma; Hidefumi Aoyama
    Journal of medical imaging and radiation oncology, 67, 1, 98, 110, 2022年11月14日, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), INTRODUCTION: Sequential boost intensity-modulated radiotherapy (SQB-IMRT) uses two different planning CTs (pCTs) and treatment plans. SQB-IMRT is a form of adaptive radiotherapy that allows for responses to changes in the shape of the tumour and organs at risk (OAR). On the other hand, dose accumulation with the two plans can be difficult to evaluate. The purpose of this study was to analyse patterns of loco-regional failure using deformable image registration (DIR) in hypopharyngeal cancer patients treated with SQB-IMRT. METHODS: Between 2013 and 2019, 102 patients with hypopharyngeal cancer were treated with definitive SQB-IMRT at our institution. Dose accumulation with the 1st and 2nd plans was performed, and the dose to the loco-regional recurrent tumour volume was calculated using the DIR workflow. Failure was classified as follows: (i) in-field (≥95% of the recurrent tumour volume received 95% of the prescribed dose); (ii) marginal (20-95%); or (iii) out-of-field (<20%). RESULTS: After a median follow-up period of 25 months, loco-regional failure occurred in 34 patients. Dose-volume histogram analysis showed that all loco-regional failures occurred in the field within 95% of the prescribed dose, with no marginal or out-of-field recurrences observed. CONCLUSION: The dosimetric analysis using DIR showed that all loco-regional failures were within the high-dose region. More aggressive treatment may be required for gross tumours.
  • Pretreatment elevated mean corpuscular volume as an indicator for high risk esophageal second primary cancer in patients with head and neck cancer.
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Seijiro Hamada; Akihiro Homma
    Auris, nasus, larynx, 2022年10月10日, [査読有り], [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVE: Esophageal cancer is the most common second primary cancer (SPC) in patients with head and neck cancer (HNC). Esophageal SPC has a negative impact on survival. Elevated mean corpuscular volume (MCV) is an accepted predictor of esophageal cancer risk. The aim of this study was to elucidate the usefulness of elevated MCV as an indicator of a high risk for esophageal SPC. METHODS: We retrospectively reviewed the medical records of patients with oropharyngeal, hypopharyngeal, and laryngeal squamous cell carcinoma who underwent chemoradiotherapy between 2003 and 2012. We excluded patients younger than 20 years or who had received treatment for esophageal cancer and who had a histologically unproven lesion. Patients were divided into two groups according to their MCV. The cut-off for MCV was defined by receiver operating characteristics curve analysis. The primary endpoint was the cumulative incidence of esophageal SPC. RESULTS: A total of 295 patients were included. The median follow-up period for surviving patients was 7.4 years and the optimal cut-off point was 99.0 fL. One hundred ninety-five patients (66%) had an MCV < 99.0 fL and 100 (34%) had an MCV ≥ 99.0 fL. The 5-year cumulative incidence in patients with an MCV < 99.0 fL and ≥ 99.0 fL was 8.7% and 27%, respectively. In the multivariate analysis, an MCV ≥ 99.0 fL (HR=2.2; 95%CI, 1.1-4.2) was an independent risk factor. CONCLUSION: MCV ≥ 99.0 fL was found to be a risk factor for esophageal SPC. We, therefore, recommend that patients with an MCV ≥ 99.0 fL should undergo intensive monitoring.
  • The utility of diffusion-weighted T2 mapping for the prediction of histological tumor grade in patients with head and neck squamous cell carcinoma.
    Noriyuki Fujima; Yukie Shimizu; Masami Yoneyama; Junichi Nakagawa; Hiroyuki Kameda; Taisuke Harada; Seijiro Hamada; Takayoshi Suzuki; Nayuta Tsushima; Satoshi Kano; Akihiro Homma; Kohsuke Kudo
    Quantitative imaging in medicine and surgery, 12, 8, 4024, 4032, 2022年08月, [国際誌]
    英語, 研究論文(学術雑誌), Background: In head and neck cancers, histopathological information is important for the determination of the tumor characteristics and for predicting the prognosis. The aim of this study was to assess the utility of diffusion-weighted T2 (DW-T2) mapping for the evaluation of tumor histological grade in patients with head and neck squamous cell carcinoma (SCC). Methods: The cases of 41 patients with head and neck SCC (21 well/moderately and 17 poorly differentiated SCC) were retrospectively analyzed. All patients received MR scanning using a 3-Tesla MR unit. The conventional T2 value, DW-T2 value, ratio of DW-T2 value to conventional T2 value, and apparent diffusion coefficient (ADC) were calculated using signal information from the DW-T2 mapping sequence with a manually placed region of interest (ROI). Results: ADC values in the poorly differentiated SCC group were significantly lower than those in the moderately/well differentiated SCC group (P<0.05). The ratio of DW-T2 value to conventional T2 value was also significantly different between poorly and moderately/well differentiated SCC groups (P<0.01). Receiver operating characteristic (ROC) curve analysis of ADC values showed a sensitivity of 0.76, specificity of 0.67, positive predictive value (PPV) of 0.62, negative predictive value (NPV) of 0.8, accuracy of 0.71 and area under the curve (AUC) of 0.73, whereas the ROC curve analysis of the ratio of DW-T2 value to conventional T2 value showed a sensitivity of 0.76, specificity of 0.83, PPV of 0.76, NPV of 0.83, accuracy of 0.8 and AUC of 0.82. Conclusions: DW-T2 mapping might be useful as supportive information for the determination of tumor histological grade in patients with head and neck SCC.
  • Amide proton transfer imaging for the determination of human papillomavirus status in patients with oropharyngeal squamous cell carcinoma.
    Noriyuki Fujima; Yukie Shimizu; Masami Yoneyama; Junichi Nakagawa; Hiroyuki Kameda; Taisuke Harada; Seijiro Hamada; Takayoshi Suzuki; Nayuta Tsushima; Satoshi Kano; Akihiro Homma; Kohsuke Kudo
    Medicine, 101, 28, e29457, 2022年07月15日, [国際誌]
    英語, 研究論文(学術雑誌), The aim of this study was to investigate the utility of amide proton transfer (APT) imaging for the determination of human papillomavirus (HPV) status in patients with oropharyngeal squamous cell carcinoma (SCC). Thirty-one patients with oropharyngeal SCC were retrospectively evaluated. All patients underwent amide proton transfer imaging using a 3T magnetic resonance (MR) unit. Patients were divided into HPV-positive and -negative groups depending on the pathological findings in their primary tumor. In APT imaging, the primary tumor was delineated with a polygonal region of interest (ROI). Signal information in the ROI was used to calculate the mean, standard deviation (SD) and coefficient of variant (CV) of the APT signals (APT mean, APT SD, and APT CV, respectively). The value of APT CV in the HPV-positive group (0.43 ± 0.04) was significantly lower than that in the HPV-negative group (0.48 ± 0.04) (P = .01). There was no significant difference in APT mean (P = .82) or APT SD (P = .13) between the HPV-positive and -negative groups. Receiver operating characteristic (ROC) curve analysis of APT CV had a sensitivity of 0.75, specificity of 0.8, positive predictive value of 0.75, negative predictive value of 0.8, accuracy of 0.77 and area under the curve (AUC) of 0.8. The APT signal in the HPV-negative group was considered heterogeneous compared to the HPV-positive group. This information might be useful for the determination of HPV status in patients with oropharyngeal SCC.
  • 頭頸部癌に対するペムブロリズマブ投与症例の後方視的検討
    清水 康; 田口 純; 鈴木 崇祥; 対馬 那由多; 加納 里志; 本間 明宏; 秋田 弘俊
    頭頸部癌, 48, 2, 145, 145, (一社)日本頭頸部癌学会, 2022年05月
    日本語
  • 内視鏡を用いたカダバー手術トレーニングにより喉頭全摘出術を咽頭側から理解する
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 本間 明宏
    頭頸部癌, 48, 2, 192, 192, (一社)日本頭頸部癌学会, 2022年05月
    日本語
  • 咽喉頭癌に対するシスプラチン超選択的動注併用放射線治療(RADPLAT)による頸部制御の検討
    加納 里志; 対馬 那由多; 鈴木 崇祥; 浜田 誠二郎; 吉田 大介; 打浪 雄介; 安田 耕一; 本間 明宏
    頭頸部癌, 48, 2, 151, 151, (一社)日本頭頸部癌学会, 2022年05月
    日本語
  • 高齢の頭頸部悪性腫瘍に対する放射線治療の後ろ向き検討
    安田 耕一; 打浪 雄介; 浜田 誠二郎; 鈴木 崇祥; 対馬 那由多; 田口 純; 清水 康; 加納 里志; 本間 明宏
    頭頸部癌, 48, 2, 200, 200, (一社)日本頭頸部癌学会, 2022年05月
    日本語
  • Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy.
    Seijiro Hamada; Satoshi Kano; Junko Murai; Takayoshi Suzuki; Nayuta Tsushima; Takatsugu Mizumachi; Masanobu Suzuki; Tsuyoshi Takashima; Daiki Taniyama; Naoya Sakamoto; Yoichiro Fujioka; Yusuke Ohba; Akihiro Homma
    Frontiers in oncology, 12, 978875, 978875, 2022年, [国際誌]
    英語, 研究論文(学術雑誌), Recently, Schlafen family member 11 (SLFN11) has been reported to increase the sensitivity of cancer cells to DNA-damaging agents, including platinum derivatives; thus, SLFN11 may be a predictive biomarker for platinum-based chemoradiotherapy (CRT). In this study, we examined whether SLFN11 expression was associated with the therapeutic outcome of platinum-based CRT in head and neck squamous cell carcinoma (HNSCC). We performed immunohistochemical analyses for SLFN11 expression in 161 HNSCC tissues from patients who had been administered cisplatin-based CRT and examined the correlation between SLFN11 expression and progression-free survival (PFS). Additionally, SLFN11 expression was examined in 10 paired samples obtained before and after CRT in patients with local failure. Furthermore, in vitro experiments were performed using several HNSCC cell lines and isogenic SLFN11-knockout cells to assess the association between SLFN11 expression and drug sensitivity. PFS was found to be significantly better in the SLFN11-positive group than in the SLFN11-negative group among the 161 patients (5-year PFS: 78.8% vs. 52.8%, respectively, p < 0.001). Similar results were observed for the PFS at each primary site. The percentage of SLFN11 positivity was lower in tumor samples from patients with local failure after CRT than that in the corresponding primary tumors before CRT in 8 of 10 cases. Results of the in vitro assay demonstrated that SLFN11-knockout cells exhibited reduced sensitivity to DNA-damaging agents but not to the non-DNA-damaging agent docetaxel. Our findings suggest that SLFN11 may serve as a potential biomarker for predicting the response of HNSCC patients to platinum-based CRT.
  • Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy.
    Satoshi Kano; Nayuta Tsushima; Takayoshi Suzuki; Seijiro Hamada; Taizo Yokokawa; Hiroshi Idogawa; Koichi Yasuda; Hideki Minatogawa; Yasuhiro Dekura; Hidefumi Aoyama; Akihiro Homma
    International journal of clinical oncology, 26, 7, 1179, 1187, 2021年07月, [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: We investigated whether prophylactic percutaneous endoscopic gastrostomy (PEG) is used effectively for patients treated with definitive concurrent chemoradiotherapy (CCRT) and the predictors of the need for PEG. METHODS: 326 patients with laryngeal, oropharyngeal or hypopharyngeal cancers were retrospectively reviewed. RESULTS: The PEG tube use group had more favorable results than the total parenteral nutrition and nasogastric tube groups in terms of rate of serum albumin loss, incidence of severe fever and aspiration pneumonia, CCRT completion rate and hospitalization period. However, it was inferior to oral intake. Analysis of the relative risk of requiring enteral or parenteral nutrition revealed that performance status (PS) 2, primary site (supraglottis, oropharynx, or hypopharynx), N3 disease, and cisplatin were predictors of the need for nutritional support. CONCLUSIONS: Prophylactic PEG is effective for patients treated with definitive CCRT and is especially required for patients with PS2 or oropharyngeal cancer.
  • 1歳男児のオトガイ下に発生した脂肪芽腫の1例
    三澤 隆一; 対馬 那由多; 横川 泰三; 加納 里志; 鈴木 崇祥; 本間 明宏
    耳鼻咽喉科臨床 補冊, 補冊157, 124, 124, 耳鼻咽喉科臨床学会, 2021年06月
    日本語
  • 涙嚢原発扁平上皮癌の3例
    滝沢 亮介; 対馬 那由多; 鈴木 崇祥; 加納 里志; 本間 明宏
    耳鼻咽喉科臨床 補冊, 補冊157, 125, 125, 耳鼻咽喉科臨床学会, 2021年06月
    日本語
  • 頭頸部癌に対するペムブロリズマブ投与症例の後方視的検討
    清水 康; 田口 純; 鈴木 崇祥; 対馬 那由多; 加納 里志; 本間 明宏; 秋田 弘俊
    頭頸部癌, 47, 2, 170, 170, (一社)日本頭頸部癌学会, 2021年05月
    日本語
  • 平均赤血球容積(MCV)高値は頭頸部癌に食道癌を併発するリスク因子である
    対馬 那由多; 加納 里志; 鈴木 崇祥; 本間 明宏
    頭頸部癌, 47, 2, 200, 200, (一社)日本頭頸部癌学会, 2021年05月
    日本語
  • 咽喉頭扁平上皮癌IMRTの照射中における線量分布変化に関する解析
    安田 耕一; 打浪 雄介; 湊川 英樹; 小泉 富基; 大塚 愛美; 藤田 祥博; 井戸川 寛志; 鈴木 崇祥; 対馬 那由多; 加納 里志; 本間 明宏
    頭頸部癌, 47, 2, 210, 210, (一社)日本頭頸部癌学会, 2021年05月
    日本語
  • CCRTを施行した頭頸部癌患者に対する予防的胃瘻増設の有用性の検討
    加納 里志; 対馬 那由多; 鈴木 崇祥; 井戸川 寛志; 浜田 誠二郎; 横川 泰三; 安田 耕一; 湊川 英樹; 打浪 雄介; 本間 明宏
    頭頸部癌, 47, 2, 211, 211, (一社)日本頭頸部癌学会, 2021年05月
    日本語
  • Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Hiroshi Idogawa; Daisuke Yoshida; Koichi Yasuda; Manami Otsuka; Hidefumi Aoyama; Akihiro Homma
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 279, 2, 899, 905, 2021年04月18日, [査読有り], [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌), PURPOSE: We have performed superselective intra-arterial cisplatin infusion with concomitant radiotherapy (RADPLAT) for patients with maxillary sinus cancer. The promising treatment outcomes of this non-surgical treatment were reported in past studies. However, few clinical studies have been conducted to evaluate the outcome of salvage surgery following RADPLAT. The purpose of this study was to analyze the treatment outcomes of salvage surgery for patients with recurrent maxillary sinus cancer after RADPLAT. METHODS: We assessed 45 patients who had recurrence following RADPLAT between 1999 and 2017, and conducted a retrospective analysis. We excluded patients who did not complete RADPLAT. Patients were not considered to have completed RADPLAT if they underwent intra-arterial cisplatin less than three times or received a total radiation dose of less than 60 Gy. The primary endpoint was overall survival. The median follow-up period for surviving patients after recurrence was 5.1 years. RESULTS: Twenty-five of the 45 (56%) patients underwent salvage surgery. The 5-year overall survival rate was 68% in patients who underwent salvage surgery, while all patients who did not undergo salvage surgery died during the observation period. Fifteen of 24 (63%) patients with local recurrence underwent salvage surgery. Eight patients did not undergo salvage surgery because of unresectable disease; five of the eight patients had unresectable posterior extension. All nine patients with nodal recurrence underwent neck dissection. CONCLUSION: Treatment outcomes of salvage surgery following RADPLAT were favorable enough for it to be generally recommended. To reduce unresectable recurrence, the posterior section should be eradicated by RADPLAT.
  • 上顎洞がん超選択的動注化学療法併用放射線治療後再発に対する救済手術は生命予後を改善する
    対馬 那由多; 加納 里志; 鈴木 崇祥; 井戸川 寛志; 本間 明宏
    日本耳鼻咽喉科学会会報, 124, 4, 583, 583, (一社)日本耳鼻咽喉科頭頸部外科学会, 2021年04月
    日本語
  • Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients.
    Koichi Yasuda; Hideki Minatogawa; Yasuhiro Dekura; Seishin Takao; Masaya Tamura; Nayuta Tsushima; Takayoshi Suzuki; Satoshi Kano; Takatsugu Mizumachi; Takashi Mori; Kentaro Nishioka; Motoyasu Shido; Norio Katoh; Hiroshi Taguchi; Noriyuki Fujima; Rikiya Onimaru; Isao Yokota; Keiji Kobashi; Shinichi Shimizu; Akihiro Homma; Hiroki Shirato; Hidefumi Aoyama
    Journal of radiation research, 62, 2, 329, 337, 2021年03月10日, [国際誌]
    英語, 研究論文(学術雑誌), Pharyngeal cancer patients treated with intensity-modulated proton therapy (IMPT) using a model-based approach were retrospectively reviewed, and acute toxicities were analyzed. From June 2016 to March 2019, 15 pharyngeal (7 naso-, 5 oro- and 3 hypo-pharyngeal) cancer patients received IMPT with robust optimization. Simulation plans for IMPT and intensity-modulated X-ray therapy (IMXT) were generated before treatment. We also reviewed 127 pharyngeal cancer patients with IMXT in the same treatment period. In the simulation planning comparison, all of the normal-tissue complication probability values for dysphagia, dysgeusia, tube-feeding dependence and xerostomia were lower for IMPT than for IMXT in the 15 patients. After completing IMPT, 13 patients completed the evaluation, and 12 of these patients had a complete response. The proportions of patients who experienced grade 2 or worse acute toxicities in the IMPT and IMXT cohorts were 21.4 and 56.5% for dysphagia (P < 0.05), 46.7 and 76.3% for dysgeusia (P < 0.05), 73.3 and 62.8% for xerostomia (P = 0.43), 73.3 and 90.6% for mucositis (P = 0.08) and 66.7 and 76.4% for dermatitis (P = 0.42), respectively. Multivariate analysis revealed that IMPT was independently associated with a lower rate of grade 2 or worse dysphagia and dysgeusia. After propensity score matching, 12 pairs of IMPT and IMXT patients were selected. Dysphagia was also statistically lower in IMPT than in IMXT (P < 0.05). IMPT using a model-based approach may have clinical benefits for acute dysphagia.
  • The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma.
    Yuji Nakamaru; Masanobu Suzuki; Satoshi Kano; Takatsugu Mizumachi; Nayuta Tsushima; Takayoshi Suzuki; Aya Honma; Akira Nakazono; Shogo Kimura; Rikiya Onimaru; Koichi Yasuda; Hiroki Shirato; Akihiro Homma
    Auris, nasus, larynx, 48, 1, 131, 137, 2021年02月, [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVE: Despite of rapid advances in endoscopic surgery, the gold standard for sinonasal squamous cell carcinoma (SNSCC) surgery has remained the open approach with en-block resection due to the aggressive nature of SNSCC, including frequent recurrence and high mortality rate. For that reason, few studies have focused on SNSCC treated by endoscopic surgery alone. The objective of this study was to evaluate the usefulness of endoscopic surgery for patients with SNSCC. METHODS: A retrospective analysis was performed for 15 consecutive SNSCC patients who underwent endoscopic surgery without an open approach. We carefully selected patients whose tumor attachment sites could be fully visualized and completely resected through an endonasal approach. RESULTS: Of the fifteen patients, 4 patients (27%) were diagnosed with T1, 7 (47%) with T2, 4 (27%) with T3, and no patients with T4a or T4b disease. Four of the 15 (27%) patients showed positive surgical margins. The 5-yr overall survival, disease-specific survival, and local control rate was 72.4%, 79.6%, and 92.9%, respectively. The 5-yr disease-specific survival for T1, T2, and T3 disease was 100% and 75% and 75%, respectively. Patients with negative surgical margins had a better disease-specific survival rate than did those with positive surgical margins (p = 0.0253). CONCLUSION: Endoscopic surgery for patients with SNSCC appears to afford an effective method in selected cases. The achievement of negative surgical margins with a good view of the tumor attachment site was considered to be critical to the management of SNSCC.
  • cStageI-II舌癌症例の後発頸部リンパ節転移の検討
    今成 隼人; 対馬 那由多; 鈴木 崇祥; 加納 里志; 本間 明宏
    耳鼻咽喉科臨床 補冊, 補冊155, 109, 109, 耳鼻咽喉科臨床学会, 2020年12月
    日本語
  • 上・中・下咽頭癌に対する陽子線治療の初期経験
    安田 耕一; 湊川 英樹; 出倉 康裕; 対馬 那由多; 鈴木 崇祥; 加納 里志; 鬼丸 力也; 清水 伸一; 本間 明宏; 青山 英史
    頭頸部癌, 46, 2, 161, 161, (一社)日本頭頸部癌学会, 2020年07月
    日本語
  • 休日による総治療期間延長に対して1回線量増加の方法を組み合わせて放射線治療を行った早期声門癌の検討
    出倉 康裕; 安田 耕一; 湊川 英樹; 対馬 那由多; 鈴木 崇祥; 加納 里志; 鬼丸 力也; 本間 明宏; 青山 英史
    頭頸部癌, 46, 2, 179, 179, (一社)日本頭頸部癌学会, 2020年07月
    日本語
  • 頭頸部粘膜悪性黒色腫に対する術後陽子線治療30GyE/5回の初期経験
    湊川 英樹; 安田 耕一; 出倉 康裕; 鈴木 正宣; 中丸 裕爾; 中薗 彬; 鈴木 崇祥; 対馬 那由多; 加納 里志; 鬼丸 力也; 清水 伸一; 本間 明宏; 青山 英史
    頭頸部癌, 46, 2, 188, 188, (一社)日本頭頸部癌学会, 2020年07月
    日本語
  • Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer.
    Nayuta Tsushima; Takeshi Shinozaki; Takao Fujisawa; Toshifumi Tomioka; Wataru Okano; Masakazu Ikeda; Makoto Tahara; Takuya Higashino; Ryuichi Hayashi
    Clinical medicine insights. Case reports, 13, 1179547620908854, 1179547620908854, 2020年, [査読有り], [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌), Objectives: Nivolumab, a fully IgG4-programmed death-1 inhibitor antibody, led to improved overall survival compared with single-agent therapy in patients with platinum-refractory recurrent head and neck cancers. In general, nivolumab is used in inoperable patients. To the best of our knowledge, there have been no reports of salvage surgery during nivolumab therapy for patients with head and neck cancer. We report the case of a woman treated with salvage reconstructive surgery during nivolumab therapy. Method: Case report and literature review. Results: The patient underwent nivolumab therapy for recurrent primary and neck disease after induction chemotherapy, followed by concurrent chemoradiation therapy. The neck disease shrunk, whereas the primary disease temporarily shrunk but later progressed again. Recurrent primary disease led to a narrowing of her airway, and she required airway management. We performed total pharyngolaryngectomy with free jejunal reconstruction, and her quality of life improved. The surgery was performed without complications and the postoperative course was uneventful. She was discharged postoperative day 18 with oral intake function and a safer airway. Conclusion: As far as we know, this is the first report of salvage surgery during nivolumab therapy for patients with head and neck cancer. The salvage reconstructive surgery in this case proceeded uneventfully.
  • Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma.
    Takayoshi Suzuki; Satoshi Kano; Masanobu Suzuki; Shinichiro Yasukawa; Takatsugu Mizumachi; Nayuta Tsushima; Kanako C Hatanaka; Yutaka Hatanaka; Yoshihiro Matsuno; Akihiro Homma
    Frontiers in oncology, 10, 603717, 603717, 2020年, [国際誌]
    英語, 研究論文(学術雑誌), Salivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer have been reported, with significant differences in HER2 expression between Ca-ex-PA and de novo. We assessed the differences in gene expression between onset classifications. We conducted immunohistochemical analysis and HER2-DISH for 23 patients and classified SDCs into three subtypes as follows: "HER2-positive" (HER2+/any AR), "Luminal-AR" (HER2-/AR+), and "Basal-like" (HER2-/AR-). We assessed the expression levels of 84 functional genes for 19 patients by using a qRT-PCR array. Ten cases were classified as HER2-positive, seven cases as Luminal-AR, and six cases as Basal-like. The gene expression pattern was generally consistent with the corresponding immunostaining classification. The expression levels of VEGFA, ERBB2(HER2), IGF1R, RB1, and XBP1 were higher, while those of SLIT2 and PTEN were lower in Ca-ex-PA than in de novo. The functions of those genes were concentrated in angiogenesis and AKT/PI3K signaling pathway (Fisher's test: p-value = 0.025 and 0.004, respectively). Multiple machine learning methods, OPLS-DA, LASSO, and RandomForest, also show that VEGFA can be a candidate for the characteristic differences between Ca-ex-PA and de novo. In conclusion, the AKT/PI3K signaling pathway leading to angiogenesis was hyper-activated in all SDCs, particularly in those classified into the Ca-ex-PAs. VEGFA was over-expressed significantly in the Ca-ex-PA, which can be a crucial factor in the malignant conversion to SDC.
  • CCRTを施行した進行頭頸部癌患者に対する予防的胃瘻増設の有用性の検討
    加納 里志; 対馬 那由多; 鈴木 崇祥; 浜田 誠二郎; 横川 泰三; 本間 明宏
    日本癌治療学会学術集会抄録集, 57回, P4, 4, (一社)日本癌治療学会, 2019年10月
    英語
  • 当科における局所進行外耳道扁平上皮癌の治療成績の検討
    加納 里志; 森田 真也; 中丸 裕爾; 水町 貴諭; 対馬 那由多; 鈴木 崇祥; 中薗 彬; 福田 篤; 安田 耕一; 鬼丸 力也; 白土 博樹; 本間 明宏
    頭頸部癌, 45, 3, 300, 304, (一社)日本頭頸部癌学会, 2019年10月
    日本語
  • The role of elective neck dissection for cT4aN0 glottic squamous cell carcinoma.
    Nayuta Tsushima; Ryuichi Hayashi; Takeshi Shinozaki; Toshifumi Tomioka; Wataru Okano; Masakazu Ikeda
    Japanese journal of clinical oncology, 49, 6, 525, 528, 2019年06月01日, [査読有り], [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVE: The indication for elective neck dissection for patients with clinically T4aN0 (cT4aN0) glottic cancer is not established. The objective of this study was to evaluate the role of elective neck dissection for patients with cT4aN0 glottic cancer. METHODS: We assessed patients with cT4aN0 laryngeal squamous cell carcinoma who underwent total laryngectomy between 1998 and 2014 and conducted a retrospective analysis. We considered occult neck metastasis positive when confirmed by histological analysis. When patients with late neck metastases did not undergo therapeutic neck dissection, the presence of occult neck metastasis was judged on the basis of computed tomography. The validity of elective neck dissection for patients with cT4aN0 glottic cancer was assessed from comparisons the rates of occult neck metastases of supraglottic and subglottic cancers, which are generally recommended for elective neck dissection. The distribution of occult neck metastases in glottic cancer is described according to nodal levels. RESULTS: The rate of occult neck metastasis of cT4aN0 laryngeal cancer was 36% (14/39). There were no significant differences among the rates of glottic 7/21 (33%), supraglottic 3/8 (38%) and subglottic 4/10 (40%) cancers. Patients with glottic cancer did not have bilateral Level IIB and ipsilateral Level IV metastasis. One patient had contralateral Level IV metastasis. The metastases rates of ipsilateral Levels IIA, III, and VI were >10%. CONCLUSIONS: We think that elective neck dissection is valid for cT4aN0 glottic cancer. Ipsilateral Levels IIA, III and VI should be dissected. The omission of neck dissection for bilateral Levels IIB and IV can be considered when there is a need to avoid complications.
  • Desmoplastic small round cell tumor of the parotid gland-report of a rare case and a review of the literature.
    Kanako C Hatanaka; Emi Takakuwa; Yutaka Hatanaka; Akira Suzuki; Satoshi IIzuka; Nayuta Tsushima; Tomoko Mitsuhashi; Shintaro Sugita; Akihiro Homma; Shojiroh Morinaga; Tadashi Hashegawa; Yoshihiro Matsuno
    Diagnostic pathology, 14, 1, 43, 43, 2019年05月18日, [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a rare soft tissue tumor that generally involves the retroperitoneum, pelvis, omentum and mesentery in younger patients. However, extra-abdominal DSRCT is very rare. CASE PRESENTATION: A 49-year-old Japanese man noticed a mass in the right parotid gland. Ultrasound examination revealed a solid tumor about 2 cm in diameter. Computed tomography (CT) of the whole body revealed no other tumors or lymph node swelling. Superficial parotidectomy was performed. Histologically, the tumor was composed of various-sized tumor cell nests in an abundant fibromyxoid and collagenous background. The tumor cells were small to medium-sized. Immunohistochemistry showed that the tumor cells were immunoreactive for epithelial markers and desmin. They also showed strong nuclear staining with a Wilms tumor 1 (WT1) antibody detecting the C-terminal region (C-WT1), but not the N-terminal region (N-WT1). We also performed 3'/5' expression imbalance assay based on reverse transcription polymerase chain reaction (RT-PCR) to determine whether aberrant WT1 gene expression was present. This tumor was found to lack 5'-regional expression of the WT1 gene, as well as immunoreactivity with the N-WT1 antibody. Finally, fluorescence in situ hybridization (FISH) and RT-PCR analyses revealed the presence of a gene showing fusion between exon 7 of EWSR1 and exon 8 of WT1. The tumor was diagnosed as a DSRCT of the right parotid gland. The patient has been followed for 3 years without recurrence or metastasis. CONCLUSIONS: Although DSRCT in the salivary gland is extremely rare, it should be included in the differential diagnosis of poorly differentiated salivary gland neoplasms, especially with a fibromyxoid background. Pathologists should bear in mind that DSRCT may occur in major salivary glands and should perform immunohistochemistry with appropriate antibodies, not only those against keratin and desmin, but also one detecting the C-terminal region of WT-1. Furthermore, molecular detection of EWSR1-WT1 fusion gene conclusively confirmed the diagnosis of DSRCT in this uncommon location.
  • 頭頸部癌症例における平均赤血球容積(MCV)と生存率の検討
    対馬 那由多; 加納 里志; 水町 貴諭; 鈴木 崇祥; 本間 明宏
    頭頸部癌, 45, 2, 165, 165, (一社)日本頭頸部癌学会, 2019年05月
    日本語
  • 舌扁平上皮癌における改訂UICC TNM分類第8版の有用性の検討
    加納 里志; 対馬 那由多; 水町 貴諭; 鈴木 崇祥; 浜田 誠二郎; 本間 明宏
    頭頸部癌, 45, 2, 157, 157, (一社)日本頭頸部癌学会, 2019年05月
    日本語
  • 多形腺腫由来型唾液腺導管癌に特徴的な遺伝子発現の探索
    鈴木 崇洋; 加納 里志; 浜田 誠二郎; 対馬 那由多; 水町 貴諭; 本間 明宏
    頭頸部癌, 45, 2, 221, 221, (一社)日本頭頸部癌学会, 2019年05月
    日本語
  • 強度変調X線治療および強度変調陽子線治療における皮膚炎と皮膚線量に関する検討
    安田 耕一; 湊川 英樹; 出倉 康裕; 対馬 那由多; 鈴木 崇祥; 加納 里志; 水町 貴諭; 鬼丸 力也; 清水 伸一; 本間 明宏; 白土 博樹
    頭頸部癌, 45, 2, 134, 134, (一社)日本頭頸部癌学会, 2019年05月
    日本語
  • 外耳道癌における強度変調陽子線治療と強度変調X線治療との線量分布の比較
    出倉 康裕; 安田 耕一; 湊川 英樹; 対馬 那由多; 鈴木 崇祥; 加納 里志; 水町 貴諭; 鬼丸 力也; 清水 伸一; 本間 明宏; 白土 博樹
    頭頸部癌, 45, 2, 138, 138, (一社)日本頭頸部癌学会, 2019年05月
    日本語
  • Treatment outcomes of local advanced external auditory canal squamous cell carcinomas
    Satoshi Kano; Shinya Morita; Yuji Nakamaru; Takatsugu Mizumachi; Nayuta Tsushima; Takayoshi Suzuki; Akira Nakazono; Atsushi Fukuda; Koichi Yasuda; Rikiya Onimaru; Hiroki Shirato; Akihiro Homma
    Japanese Journal of Head and Neck Cancer, 45, 3, 300, 304, 2019年, [査読有り]
    研究論文(学術雑誌)
  • 副咽頭間隙腫瘍に対する内視鏡補助下経口的摘出術の検討
    加納 里志; 水町 貴諭; 対馬 那由多; 本間 明宏
    口腔・咽頭科, 31, 3, 360, 360, 日本口腔・咽頭科学会, 2018年08月
    日本語
  • 慢性肉芽腫症に対する骨髄移植後に発生した小児甲状腺乳頭癌の1例
    坂下 智博; 本間 明宏; 対馬 那由多; 川浪 康太郎; 福田 諭
    北海道医学雑誌, 93, 1, 70, 70, 北海道医学会, 2018年05月
    日本語
  • ニボルマブ投与後に原発巣再発を生じ,遊離組織移植を伴う手術を施行した1例
    対馬 那由多; 篠崎 剛; 富岡 利文; 岡野 渉; 東野 琢也; 田原 信; 林 隆一
    頭頸部癌, 44, 2, 230, 230, (一社)日本頭頸部癌学会, 2018年05月
    日本語
  • Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma
    Satoshi Kano; Tomohiro Sakashita; Nayuta Tsushima; Takatsugu Mizumachi; Akira Nakazono; Takayoshi Suzuki; Shinichiro Yasukawa; Akihiro Homma
    International Journal of Clinical Oncology, 23, 5, 1, 7, Springer Tokyo, 2018年04月19日, [査読有り]
    英語, 研究論文(学術雑誌)
  • 舌扁平上皮癌における新しいTNM分類の有用性の検討
    加納 里志; 水町 貴諭; 対馬 那由多; 鈴木 崇祥; 中薗 彬; 安川 真一郎; 本間 明宏
    日本耳鼻咽喉科学会会報, 121, 4, 578, 578, (一社)日本耳鼻咽喉科頭頸部外科学会, 2018年04月
    日本語
  • 舌扁平上皮癌における新しいTNM分類の有用性の検討
    加納 里志; 水町 貴諭; 対馬 那由多; 鈴木 崇祥; 中薗 彬; 安川 真一郎; 本間 明宏
    日本耳鼻咽喉科学会会報, 121, 4, 578, 578, (一社)日本耳鼻咽喉科学会, 2018年04月
    日本語
  • 経口的切除術後に嚥下障害を生じた中咽頭、下咽頭重複癌の1例
    対馬 那由多; 富岡 利文; 矢野 友規; 篠崎 剛; 丸尾 貴志; 岡野 渉; 林 隆一
    耳鼻咽喉科展望, 61, 1, 64, 65, 耳鼻咽喉科展望会, 2018年02月
    日本語
  • 北海道大学病院における舌癌治療の現況・選択的動注化学療法の意義
    坂下 智博; 本間 明宏; 畠山 博充; 加納 里志; 水町 貴諭; 蠣崎 文彦; 対馬 那由多; 福田 諭
    耳鼻咽喉科展望, 60, 補冊1, 50, 51, 耳鼻咽喉科展望会, 2017年06月
    日本語
  • 喉頭癌cT4aN0症例における潜在的頸部転移リンパ節転移の検討
    対馬 那由多; 篠崎 剛; 富岡 利文; 岡野 渉; 樽谷 貴之; 六郷 正博; 林 隆一
    頭頸部癌, 43, 2, 214, 214, (一社)日本頭頸部癌学会, 2017年05月
    日本語
  • The role of prophylactic neck dissection and tumor thickness evaluation for patients with cN0 tongue squamous cell carcinoma
    Nayuta Tsushima; Tomohiro Sakashita; Akihiro Homma; Hiromitsu Hatakeyama; Satoshi Kano; Takatsugu Mizumachi; Tomohiko Kakizaki; Takayoshi Suzuki; Satoshi Fukuda
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 273, 11, 3987, 3992, 2016年11月, [査読有り], [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌)
  • 舌癌N0症例における予防的頸部郭清術の役割と潜在的頸部転移陽性率に関する検討
    坂下 智博; 本間 明宏; 対馬 那由多; 福田 諭
    口腔・咽頭科, 29, 3, 401, 401, 日本口腔・咽頭科学会, 2016年08月
    日本語
  • 下咽頭癌に対するCisplatin週1回放射線化学療法と導入化学療法の有用性と治療完遂率に関する検討
    坂下 智博; 対馬 那由多; 本間 明宏; 水町 貴諭; 福田 諭
    口腔・咽頭科, 29, 2, 169, 174, 日本口腔・咽頭科学会, 2016年06月
    日本語
  • 抗甲状腺薬による無顆粒球症に急性喉頭蓋炎、深頸部膿瘍を併発し、気道確保と頸部切開排膿を要した1例
    対馬 那由多; 赤澤 茂; 木村 将吾
    頭頸部外科, 26, 1, 37, 42, (NPO)日本頭頸部外科学会, 2016年06月
    日本語
  • 梨状陥凹原発扁平上皮癌に対するシスプラチン週一回投与併用放射線化学療法の検討
    対馬 那由多; 坂下 智博; 本間 明宏; 水町 貴諭; 福田 諭
    口腔・咽頭科, 28, 3, 367, 367, 日本口腔・咽頭科学会, 2015年08月
    日本語
  • 耳鼻咽喉科医が行う経皮的気管切開術 専門医研修への導入
    古田 康; 対馬 那由多; 中薗 彬; 福田 篤; 木村 将吾; 高橋 紘樹; 津布久 崇; 松村 道哉
    日本耳鼻咽喉科学会会報, 118, 12, 1443, 1448, (一社)日本耳鼻咽喉科学会, 2015年
    日本語, 研究論文(学術雑誌)
  • Introduction of percutaneous dilational tracheotomy in otolaryngology residency training
    Yasushi Furuta; Nayuta Tsushima; Akira Nakazono; Atsushi Fukuda; Shogo Kimura; Hiroki Takahashi; Takashi Tsubuku; Michiya Matsumura
    Journal of Otolaryngology of Japan, 118, 12, 1443, 1448, Oto-Rhino-Laryngological Society of Japan Inc., 2015年, [査読有り]
    日本語, 研究論文(学術雑誌)
  • 原発不明頸部転移癌例の検討
    対馬 那由多; 黒田 徹
    耳鼻咽喉科臨床, 106, 7, 637, 643, 耳鼻咽喉科臨床学会, 2013年07月
    日本語, 研究論文(学術雑誌)
  • 原発不明頸部転移癌4例の検討
    対馬 那由多; 黒田 徹
    耳鼻咽喉科臨床 補冊, 補冊133, 158, 158, 耳鼻咽喉科臨床学会, 2012年07月
    日本語
  • 輪状軟骨鉗除による気管孔形成術の検討
    蠣崎 文彦; 津布久 崇; 対馬 那由多; 松村 道哉; 古田 康
    頭頸部外科, 22, 1, 87, 92, (NPO)日本頭頸部外科学会, 2012年06月
    日本語
  • 甲状腺低分化癌に対する放射線治療後に頸椎炎から咽後膿瘍をきたした一例
    中薗 彬; 対馬 那由多; 津布 久崇; 松村 道哉; 古田 康; 安川 真一郎; 坂下 智博; 畠山 博充; 折舘 伸彦; 福田 諭
    北海道医学雑誌, 86, 6, 304, 304, 北海道医学会, 2011年11月
    日本語
  • 術後感染予防に対するレボフロキサシン(クラビット)の術前単回投与の有用性について
    対馬 那由多; 本間 明宏; 福田 諭
    耳鼻と臨床, 56, 6, 254, 258, 耳鼻と臨床会, 2010年11月
    日本語
  • 甲状腺術後反回神経麻痺に対する音声外科手術の検討
    古田 康; 対馬 那由多; 津布久 崇; 松村 道哉; 目須田 康; 折舘 伸彦
    北海道医学雑誌, 85, 5, 348, 348, 北海道医学会, 2010年09月
    日本語
■ その他活動・業績
■ 講演・口頭発表等
  • Genetic Drivers of Japanese Sinonasal Mucosal Melanoma: Clinical Implications of NRAS and CTNNB1
    Nayuta Tsushima
    9th Conference of the Asian Society of Head & Neck Oncology, 2025年11月02日, 英語, 口頭発表(一般)
    2025年11月01日 - 2025年11月02日
  • NRAS and CTNNB1 as Major Mutational Drivers in Japanese Sinonasal Mucosal Melanoma
    Nayuta Tsushima
    21st ASEAN ORL HNS Congress, 2025年10月11日, 英語, 口頭発表(一般)
    2025年10月10日 - 2025年10月12日
  • 鼻副鼻腔粘膜悪性黒色腫における現状と課題
    第49回 日本頭頸部癌学会総会・学術講演会, 2025年06月13日, シンポジウム・ワークショップパネル(指名)
    2025年06月13日 - 2025年06月14日, 40312446
  • Treatment outcomes of sinonasal mucosal melanoma: usefulness of endoscopic surgery and postoperative radiotherapy
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Seijiro Hamada; Hiroshi Idogawa; Akihiro Homma
    3rd International Congress of the Asian Oncology Society in conjunction with the 61st Annual Meeting of Japan Society of Clinical Oncology, 2023年10月21日, 英語, 口頭発表(一般)
    2023年10月18日 - 2023年10月21日
  • Treatment outcome of endoscopic surgery and postoperative radiotherapy for sinonasal mucosal melanoma
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Seijiro Hamada; Koichi Yasuda; Hidefumi Aoyama; Akihiro Homma
    AHNS 11th International Conference on Head and Neck Cancer, 2023年07月09日, 英語
    2023年07月08日 - 2023年07月12日
  • 次世代シークエンサーに よる鼻副鼻腔粘膜悪性黒色腫の遺伝子発現解析
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 本間 明宏
    第47回日本頭頸部癌学会総 会・学術講演会, 2023年06月15日, 日本語, 口頭発表(一般)
    2023年06月15日 - 2023年06月16日, 40312446
  • Salvage surgery improves the treatment outcome of residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiotherapy
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Seijiro Hamada; Koichi Yasuda; Hidefumi Aoyama; Akihiro Homma
    15th Asia Oceania ORL-HNS Congress, 2023年03月08日, 英語, ポスター発表
    2023年03月08日 - 2023年03月12日
  • 鼻副鼻腔悪性黒色腫根治治療例の検討
    対馬 那由多; 加納 里志; 鈴木 崇祥; 浜田 誠二郎; 八木 建樹; 本間 明宏
    第31回日本頭頸部外科学会総会ならびに学術講演会, 2022年03月04日, 日本語, 口頭発表(一般)
    2022年03月03日 - 2022年03月04日
  • 頭頸部がんの手術
    対馬 那由多
    北海道大学病院 腫瘍センター 市民公開講座 頭頸部がん特集, 2022年02月10日, 公開講演,セミナー,チュートリアル,講習,講義等
    2022年02月10日 - 2022年02月10日
  • 舌癌のステージングと標準治療
    対馬 那由多
    がんプロフェッショナル養成プラン講演, 2021年01月25日, 公開講演,セミナー,チュートリアル,講習,講義等
    2021年01月25日 - 2021年01月25日
  • The running pattern of cervical transverse arteries can be estimated using computed tomography imaging
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Akihiro Homma
    15th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery, 2019年12月07日, 口頭発表(一般)
    2019年12月06日 - 2019年12月07日
  • Pretreatment Mean Corpuscular Volume as a Prognostic Factor for Head and Neck Cancer
    Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Akihiro Homma
    18th ASEAN Otorhinolaryngology Head & Neck Surgery Congress, 2019年08月23日, ポスター発表
    2019年08月23日 - 2019年08月25日
  • Validity of endoscopic resection and postoperative radiation therapy for treatment of sinonasal malignant melanoma
    Nayuta Tsushima; Satoshi Kano; Takatsugu Mizumachi; Takayoshi Suzuki; Akihiro Homma
    International Congress of ORL-HNS 2019, 2019年04月26日, ポスター発表
    2019年04月25日 - 2019年04月29日
  • 教育パネルディスカッション「頸部手術の急所・難所」 頸部郭清術
    対馬 那由多
    第30回日本頭頸部外科学会総会ならびに学術講演会, 2019年01月31日, シンポジウム・ワークショップパネル(指名)
    2019年01月30日 - 2019年01月31日
  • Efficacy of weekly cisplatin chemoradiotherapy with pyriform sinus squamous cell carcinoma
    Nayuta Tsushima; Tomohiro Sakashita; Akihiro Homma; Hiromitsu Hatakeyama; Takatsugu Mizumachi; Satoshi Kano; Tomohiko Kakizaki; Takayoshi Suzuki; Rikiya Onimaru; Kazuhiko Tsuchiya; Hiroki Shirato; Satoshi Fukuda
    13th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery, 2015年12月04日, 口頭発表(一般)
    2015年12月03日 - 2015年12月04日
  • Clinical evaluation of weekly cisplatin chemoradiotherapy with pyriform sinus squamous cell carcinoma
    Nayuta Tsushima; Tomohiro Sakashita; Akihiro Homma; Satoshi Fukuda
    23rd Asia Pacific Cancer Conference 2015.8.20-22(Bali, Indonesia), 2015年08月21日, 口頭発表(一般)
    2015年08月20日 - 2015年08月22日
■ 主な担当授業
  • 診療参加型選択科臨床実習, 2024年, 学士課程, 医学部
■ 共同研究・競争的資金等の研究課題
  • 遺伝子変異からアプローチする鼻副鼻腔粘膜悪性黒色腫の遠隔転移制御と生命予後向上
    科学研究費助成事業
    2025年04月01日 - 2029年03月31日
    対馬 那由多
    日本学術振興会, 若手研究, 北海道大学, 25K20155
  • 遺伝子解析による鼻副鼻腔悪性黒色腫新規治療標的分子の同定
    科学研究費助成事業 若手研究
    2019年04月 - 2023年03月
    対馬 那由多
    予定では2年目以降は得られた臨床データと遺伝子情報からバイオマーカーや治療標的分子を同定することとしていた。
    1年目に同定していた病理検体のパラフィンブロックからmacro dissectionにより標本を切り出し、遺伝子情報の解析を開始した。鼻副鼻腔悪性黒色腫の手術検体からDNA、RNAを抽出し、次世代シークエンサーを用いてのシークエンス解析を施行した。得られた解析結果から遺伝子変異を確認し、これまでの鼻副鼻腔以外の粘膜悪性黒色腫の論文と比較を行っている。皮膚悪性黒色腫と比較し、鼻副鼻腔悪性黒色に限定した報告は非常に数が少ない。日本を含めたアジア圏の報告となるとその数はわずかであるため、得られた解析結果の解釈は慎重にすべきと考えている。同定された遺伝子変異の病的意義を確認中であるとともに、本研究で着目している遠隔転移の発生との関連を臨床データとも照らし合わせて現在解析中である。これまでに「鼻副鼻腔悪性黒色腫」および我々が生命予後に直結すると考えている「遠隔転移の発生」に着目した研究は報告されておらず、有意な病的遺伝子を同定できた際には術後補助療法として確立している術後放射線照射のみではなく、術後補助薬物療法も確立できることが考えられる。本研究開始時と比較し、免疫チェックポイント阻害薬の使用など粘膜悪性黒色腫に対する薬物治療は一般的になっている。遺伝子異常が同定された場合、術後補助薬物療法への導入は以前より容易な状況と考えている。
    日本学術振興会, 若手研究, 北海道大学, 19K18754